DIS
68
-4
FTI
61
-3
SCHW
37
-3
KEY
24
-6
EBAY
39
-4
O
15
-11
CTSH
51
-3
EMC
39
-3
DD
42
-3
MAT
42
-3
CHD
34
-5
OMC
37
-2
AIZ
66
-2
ED
40
-2
BLK
52
-2
PPL
44
-3
F
40
-2
CHRW
51
-2
MSFT
54
-3
MOS
36
-3
DIS
68
-4
FTI
61
-3
SCHW
37
-3
KEY
24
-6
EBAY
39
-4
O
15
-11
CTSH
51
-3
EMC
39
-3
DD
42
-3
MAT
42
-3
CHD
34
-5
OMC
37
-2
AIZ
66
-2
ED
40
-2
BLK
52
-2
PPL
44
-3
F
40
-2
CHRW
51
-2
MSFT
54
-3
MOS
36
-3
Financhill
Back

Virtus LifeSci Biotech Clinical Trials ETF Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
42

BBC
Virtus LifeSci Biotech Clinical Trials ETF

Last Price:
$24.63
Seasonality Move:
-2.69%

7 Day Trial

ALL ACCESS PASS

$ 7

Virtus LifeSci Biotech Clinical Trials ETF Stock Forecast

  • Over the next 52 weeks, Virtus LifeSci Biotech Clinical Trials ETF has on average historically risen by 5% based on the past 9 years of stock performance.
  • Virtus LifeSci Biotech Clinical Trials ETF has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
  • Is Virtus LifeSci Biotech Clinical Trials ETF Stock Undervalued?
    The current Virtus LifeSci Biotech Clinical Trials ETF [BBC] share price is $24.33. The Score for BBC is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • BBC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Virtus LifeSci Biotech Clinical Trials ETF Stock Go Up Next Year?

  • Over the next 52 weeks, Virtus LifeSci Biotech Clinical Trials ETF has on average historically risen by 5% based on the past 9 years of stock performance.

Virtus LifeSci Biotech Clinical Trials ETF Stock Rating

Sell
42
Virtus LifeSci Biotech Clinical Trials ETF (BBC) is a Sell

Is Virtus LifeSci Biotech Clinical Trials ETF overpriced?

  • Virtus LifeSci Biotech Clinical Trials ETF has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%

Virtus LifeSci Biotech Clinical Trials ETF Stock Price History

Is BBC stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBC is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NYSEARCA
Country:
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
31.99
52-Week Low:
23.66

Prediction Charts

Market Cap:
0
Price in USD:
24.33
Volume:
2.6K
Beta:
1.28

Technical Analysis

SMA50:
27.72
SMA100:
27.68
SMA200:
27.44
52-Wk Change:
-1.93%

Stock Predictions

  • Is Virtus LifeSci Biotech Clinical Trials ETF stock public?
    Yes, Virtus LifeSci Biotech Clinical Trials ETF is a publicly traded company.
  • What is the Virtus LifeSci Biotech Clinical Trials ETF stock quote today?
    The Virtus LifeSci Biotech Clinical Trials ETF stock price is 24.33 USD today.
  • How to buy Virtus LifeSci Biotech Clinical Trials ETF stock online?
    You can buy Virtus LifeSci Biotech Clinical Trials ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-6 26.64 27.32 27.36 26.64
Dec-9 27.28 27.08 27.33 27.08
Dec-10 27.44 27.17 27.49 27.10
Dec-11 27.21 26.97 27.21 26.69
Dec-12 26.50 25.56 26.58 25.56
Dec-13 25.12 25.05 25.12 25.02
Dec-16 25.18 25.55 25.68 25.18
Dec-17 25.39 25.49 25.56 25.37
Dec-18 24.94 23.90 25.22 23.84
Dec-19 24.03 24.23 24.38 23.96
Dec-20 24.13 24.33 24.52 24.13
Dec-24 24.29 24.49 24.49 24.16
Dec-26 24.34 24.91 24.91 24.28
Dec-27 25.03 24.33 25.03 24.17

Virtus LifeSci Biotech Clinical Trials ETF Earnings

Data Unavailable

Virtus LifeSci Biotech Clinical Trials ETF Forecast Revenue Growth

Data Unavailable

* Virtus LifeSci Biotech Clinical Trials ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.